Using Intensity Modulated Radiotherapy for Endometrial Cancer with a Pelvic Kidney
Author Information
Author(s): Castilho Marcus S, Jacinto Alexandre A, Viani Gustavo A, Campana Andre, Carvalho Juliana, Ferrigno Robson, Novaes Paulo ERS, Fogaroli Ricardo C, Salvajoli Joao V
Primary Institution: Hospital do Câncer A C Camargo, São Paulo, Brazil
Hypothesis
Can Intensity Modulated Radiotherapy (IMRT) effectively treat endometrial cancer in patients with a pelvic kidney while minimizing radiation damage to the kidney?
Conclusion
IMRT is a valid technique to prevent the kidney from radiation damage.
Supporting Evidence
- The patient was free from relapse and had normal kidney function after treatment.
- IMRT allowed for the treatment of the target volume while protecting normal tissue.
- The prescribed dose was kept under tolerable limits for the pelvic kidney.
Takeaway
Doctors used a special type of radiation treatment to help a woman with cancer while making sure her kidney didn't get hurt.
Methodology
The patient received IMRT with a prescribed dose of 45 Gy, using seven co-planar fields to protect the pelvic kidney.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
A 50-year-old Caucasian woman with endometrial cancer and a pelvic kidney.
Statistical Information
P-Value
p = 0.06
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website